Ben Shaw: Covetrus can be as big a disruptor as IDEXX

摘要

Last month, animal health's newest billion-dollar business - Covetrus - was created and launched on the Nasdaq. Animal Pharm editor Joseph Harvey spoke to the company's president and chief executive Ben Shaw about his roots in animal health and the change Covetrus can bring to the wider veterinary sector.In the past few years, the manufacturers in the animal health industry has been broadening its scope beyond disease treatments and preventatives. Many of the leading businesses are becoming much moreinvolved in genomics, diagnostics and digital technology in an attempt to provide a more holistic approach to their customers' needs.In the same vein, diagnostics firms and distributors have been evolving their veterinary clinic technologies - Covetrusand IDEXX being the main examples of this.